Prognostic value of metabolic volume measured by F-18 FDG PET-CT in patients with esophageal cancer
Open Access
- 6 February 2012
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 3 (3), 255-261
- https://doi.org/10.1111/j.1759-7714.2012.00120.x
Abstract
Purpose: The aim of this study was to evaluate the usefulness of the metabolic tumor volume (MTV) measured by F-18 Fluorodeoxyglucose positron emission tomography (FDG PET-CT) in predicting recurrence free survival (RFS) in patients with esophageal cancer. Methods: Forty-five patients with squamous cell carcinoma, who had undergone whole-body F-18 FDG PET-CT scans before surgical resection, were included in this study. All patients were treated with Ivor-Lewis esophagectomy. The MTV was quantified within the primary tumor using the 50% threshold of the maximum standardized uptake value (SUVmax) of the FDG uptake areas. The cutoff value of MTV50 was determined through receiver-operating characteristic curve. The Kaplan Meier method was used to find out the relationship between RFS and MTV50. Univariate analysis and multivariate proportional hazards regression analysis were applied to test the significance of volumetric parameter of F-18 FDG PET-CT and other conventional prognostic factors for the prediction of RFS. Results: Overall median follow up period was 17.87 months (range: 1.07–63.27 months). The median survival between treatment completion and recurrence was 15.5 months (range: 1.37–72.43 months). Recurrence was found in eight patients. On univariate analysis, MTV50 (P = 0.0032), N stage (P = 0.0004), American Joint Committee on Cancer stage (P = 0.0101), tumor location (P = 0.0054) and adjuvant treatment (P = 0.0373) were significant predictors of RFS. Multivariate analysis showed that the independent prognostic factors were MTV50 (P = 0.0465), N stage (P = 0.0303) and tumor location (P = 0.0270). Conclusion: Volume based parameter of F-18 FDG PET-CT may have a role in providing prognostic information in esophageal cancer patients who received esophagectomy.Keywords
This publication has 25 references indexed in Scilit:
- Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancerCancer Treatment Reviews, 2011
- The prognostic significance of tumor laterality in patients with esophageal squamous cell carcinomaJournal of Surgical Oncology, 2011
- Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I–III small cell lung cancer: A hypothesis generating studyRadiotherapy and Oncology, 2011
- Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology, 2009
- Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the EsophagusJournal of Nuclear Medicine, 2007
- Survival after resection for primary lung cancer: a population based study of 3211 resected patientsThorax, 2006
- Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinomaBritish Journal of Surgery, 2004
- Significant Host- and Tumor-Related Factors for Predicting Prognosis in Patients With Esophageal CarcinomaAnnals of Surgery, 2003
- Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinomaCancer, 2003
- Combined radiochemotherapy for postoperative recurrence of oesophageal cancer.Gut, 1995